🇺🇸 thiazide diuretics in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 11

Most-reported reactions

1. Hepatic Enzyme Increased — 2 reports (18.18%)
2. Abdominal Pain — 1 report (9.09%)
3. Alanine Aminotransferase Increased — 1 report (9.09%)
4. Aspartate Aminotransferase Increased — 1 report (9.09%)
5. Blood Glucose Increased — 1 report (9.09%)
6. Blood Pressure Inadequately Controlled — 1 report (9.09%)
7. Blood Triglycerides Increased — 1 report (9.09%)
8. Bronchospasm — 1 report (9.09%)
9. Cholelithiasis — 1 report (9.09%)
10. Continuous Haemodiafiltration — 1 report (9.09%)

Source database →

Frequently asked questions

Is thiazide diuretics approved in United States?

thiazide diuretics does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for thiazide diuretics in United States?

Seiji Umemoto, M.D., Ph.D. is the originator. The local marketing authorisation holder may differ — check the official source linked above.